+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Should a statin be routinely prescribed for primary prevention of cardiovascular disease in diabetes mellitus?



Should a statin be routinely prescribed for primary prevention of cardiovascular disease in diabetes mellitus?



Canadian Medical Association Journal 171(8): 857-857




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 063310167

Download citation: RISBibTeXText

DOI: 10.1503/cmaj.1041490


Related references

Statin for the primary prevention of cardiovascular disease in patients with diabetes mellitus. Diabetes and Metabolism Journal 38(1): 32-34, 2014

Primary prevention of cardiovascular disease with statin in type 2 diabetes mellitus: Is it time to change our strategy?. Medicina Clinica 142(8): 358-359, 2014

Statin Therapy: Diabetes Mellitus Risk and Cardiovascular Benefit in Primary Prevention. Israel Medical Association Journal 20(8): 480-485, 2018

Statin utilization patterns for the primary prevention of cardiovascular events: a retrospective study in patients with diabetes mellitus in Hong Kong. American Journal of Cardiovascular Drugs 8(3): 199-205, 2008

PS41Characteristics Associated with Statin Prescribing for Primary Prevention of Cardiovascular Disease Among People with Diabetes. Journal of Epidemiology & Community Health 66(Suppl 1): A54.1-A54, 2012

Primary Prevention of Cardiovascular Disease in Diabetes Mellitus. Journal of the American College of Cardiology 70(7): 883-893, 2017

Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetes. Indian Journal of Medical Research 138(4): 461-491, 2013

Factors associated with statin treatment for the primary prevention of cardiovascular disease in people within 2 years following diagnosis of diabetes in Scotland, 2006-2008. Diabetic Medicine 31(6): 640-646, 2015

Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease. Circulation 133(16): 1574-1581, 2016

Balancing Primary Prevention and Statin-Induced Diabetes Mellitus Prevention. American Journal of Cardiology 120(7): 1122-1128, 2017

Aspirin therapy and primary prevention of cardiovascular disease in diabetes mellitus. Diabetes Obesity and Metabolism 11(11): 997, 2009

Primary and secondary prevention strategy for cardiovascular disease in diabetes mellitus. Cardiology Clinics 29(1): 47-70, 2011

Statin and aspirin therapy for the prevention of cardiovascular events in patients with type 2 diabetes mellitus. Clinical Cardiology 35(12): 722-729, 2012

Role of statins for the primary prevention of cardiovascular disease in patients with type 2 diabetes mellitus. American Journal of Health-System Pharmacy 64(15): 1603-1610, 2007

Role of aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: a meta-analysis. Expert Opinion on PharmacoTherapy 11(9): 1459-1466, 2010